Genomics is stepping up to buy Scale Biosciences and its single-cell profiling solutions, with plans to implement them within ...

Biotech company 10x Genomics (NASDAQ:TXG) in Q2 CY2025, with sales up 12.9% year on year to $172.9 million. On the other hand ...

An exclusive interview with Serge Saxonov of 10x Genomics and Giovanna Prout of Scale Biosciences on what the acquisition means for single cell genomics.

10x Genomics has agreed to acquire Scale Biosciences in a cash-and-stock deal worth $30 million. The life science technology company said Thursday the deal also includes contingent consideration that ...

Reports Q2 revenue $172.9M, consensus $139.51M. “The second quarter unfolded largely as anticipated,” said Serge Saxonov, Co-founder and CEO of ...

PLEASANTON, Calif. (AP) — 10x Genomics Inc. (TXG) on Thursday reported second-quarter profit of $34.5 million.